An oxytocin receptor agonist is a compound that acts as an agonist of the oxytocin receptor. They include peptides like oxytocin and carbetocin and small-molecules like LIT-001. Peptide oxytocin receptor agonists are used medically to induce labor, promote lactation, and for certain other uses.
Oxytocin receptor agonists are of theoretical interest for the potential treatment of neuropsychiatric disorders with social symptoms, such as autism, social anxiety, and psychopathy. Small-molecule oxytocin receptor agonists are considered to be more promising for such uses due to better potential pharmacokinetic profiles, such as bloodâÂÂbrain barrier permeability, elimination half-lives, and oral bioavailability.
In April 2025, a series of novel and highly potent small-molecule oxytocin receptor agonists with high selectivity over the vasopressin V<sub>1A</sub> receptor (up to >5,000-fold) were patented and described.